Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 21, 2019; 25(39): 6025-6040
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6025
Published online Oct 21, 2019. doi: 10.3748/wjg.v25.i39.6025
Figure 3 Healing rates of peptic ulcers between allicin and control groups (intent-to-treat analysis).
The healing rate of ulcers after H. pylori eradication therapy in the allicin group was significantly higher that of the control group for ITT analysis (86.17% (349/405) vs 75.87% (305/402), odds ratio = 2.05, 95% confidence interval: 1.39-3.03, P < 0.001). CI: Confidence interval.
- Citation: Si XB, Zhang XM, Wang S, Lan Y, Zhang S, Huo LY. Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis. World J Gastroenterol 2019; 25(39): 6025-6040
- URL: https://www.wjgnet.com/1007-9327/full/v25/i39/6025.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i39.6025